Department of Cardiothoracic Critical Care Medicine and ECMO, Glenfield Hospital, University Hospitals of Leicester National Health Service Trust, Leicester, UK.
Department of Cardiovascular Sciences, University of Leicester, UK.
Anaesthesia. 2022 Oct;77(10):1137-1151. doi: 10.1111/anae.15806. Epub 2022 Jul 21.
Veno-venous extracorporeal membrane oxygenation is indicated in patients with acute respiratory distress syndrome and severely impaired gas exchange despite evidence-based lung protective ventilation, prone positioning and other parts of the standard algorithm for treating such patients. Extracorporeal support can facilitate ultra-lung-protective ventilation, meaning even lower volumes and pressures than standard lung-protective ventilation, by directly removing carbon dioxide in patients needing injurious ventilator settings to maintain sufficient gas exchange. Injurious ventilation results in ventilator-induced lung injury, which is one of the main determinants of mortality in acute respiratory distress syndrome. Marked reductions in the intensity of ventilation to the lowest tolerable levels under extracorporeal support may be achieved and could thereby potentially mitigate ventilator-induced lung injury and theoretically patient self-inflicted lung injury in spontaneously breathing patients with high respiratory drive. However, the benefits of this strategy may be counterbalanced by the use of continuous deep sedation and even neuromuscular blocking drugs, which may impair physical rehabilitation and impact long-term outcomes. There are currently a lack of large-scale prospective data to inform optimal invasive ventilation practices and how to best apply a holistic approach to patients receiving veno-venous extracorporeal membrane oxygenation, while minimising ventilator-induced and patient self-inflicted lung injury. We aimed to review the literature relating to invasive ventilation strategies in patients with acute respiratory distress syndrome receiving extracorporeal support and discuss personalised ventilation approaches and the potential role of adjunctive therapies in facilitating lung protection.
静脉-静脉体外膜肺氧合适用于急性呼吸窘迫综合征患者,尽管有基于证据的肺保护性通气、俯卧位和治疗此类患者的标准方案的其他部分,但这些患者的气体交换仍严重受损。体外支持可以通过直接清除需要损伤性呼吸机设置以维持足够气体交换的患者体内的二氧化碳,从而促进超肺保护性通气,即比标准肺保护性通气更低的容量和压力。损伤性通气导致呼吸机相关性肺损伤,这是急性呼吸窘迫综合征患者死亡率的主要决定因素之一。在体外支持下,可以将通气强度降至最低耐受水平,从而有可能减轻呼吸机相关性肺损伤,并且理论上可以减轻自主呼吸高驱动患者的自发性肺损伤。然而,这种策略的好处可能会被持续深度镇静甚至神经肌肉阻滞剂的使用所抵消,这可能会影响身体康复和长期预后。目前缺乏大规模前瞻性数据来告知最佳有创通气实践以及如何最好地对接受静脉-静脉体外膜肺氧合的患者采用整体方法,同时尽量减少呼吸机相关性和患者自伤性肺损伤。我们旨在回顾与接受体外支持的急性呼吸窘迫综合征患者的有创通气策略相关的文献,并讨论个性化通气方法以及辅助治疗在促进肺保护方面的潜在作用。